Biosergen AB (publ) (STO:BIOSGN)
Sweden · Delayed Price · Currency is SEK 9.10
-0.70 (-7.14%)
May 21, 2026, 12:20 PM CET
Biosergen AB Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
23.01M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Alzinova AB | 25.66M |
| Fluicell AB | 20.06M |
| ExpreS2ion Biotech Holding AB | 10.85M |
| Spago Nanomedical AB | 4.38M |
| Aptahem AB | 2.59M |
| 2cureX AB | 1.98M |
| Pila Pharma AB | 1.13M |
| NanoEcho AB | 649.00K |
Biosergen AB News
- 3 months ago - Biosergen AB Quarterly report: Q4 2025 - Filings
- 6 months ago - Biosergen AB Quarterly report: Q3 2025 - Filings
- 9 months ago - Biosergen AB Quarterly report: Q2 2025 - Filings
- 1 year ago - Biosergen AB Quarterly report: Q1 2025 - Filings